1. Home
  2. ASMB vs MSW Comparison

ASMB vs MSW Comparison

Compare ASMB & MSW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ASMB
  • MSW
  • Stock Information
  • Founded
  • ASMB 2005
  • MSW 2012
  • Country
  • ASMB United States
  • MSW Hong Kong
  • Employees
  • ASMB N/A
  • MSW N/A
  • Industry
  • ASMB Biotechnology: Pharmaceutical Preparations
  • MSW
  • Sector
  • ASMB Health Care
  • MSW
  • Exchange
  • ASMB Nasdaq
  • MSW NYSE
  • Market Cap
  • ASMB 92.1M
  • MSW 106.5M
  • IPO Year
  • ASMB 2010
  • MSW 2024
  • Fundamental
  • Price
  • ASMB $13.61
  • MSW $8.33
  • Analyst Decision
  • ASMB Buy
  • MSW
  • Analyst Count
  • ASMB 2
  • MSW 0
  • Target Price
  • ASMB $35.00
  • MSW N/A
  • AVG Volume (30 Days)
  • ASMB 25.5K
  • MSW 441.8K
  • Earning Date
  • ASMB 03-27-2025
  • MSW 02-25-2025
  • Dividend Yield
  • ASMB N/A
  • MSW N/A
  • EPS Growth
  • ASMB N/A
  • MSW N/A
  • EPS
  • ASMB N/A
  • MSW 0.21
  • Revenue
  • ASMB $28,326,000.00
  • MSW $27,572,692.00
  • Revenue This Year
  • ASMB $282.16
  • MSW N/A
  • Revenue Next Year
  • ASMB N/A
  • MSW N/A
  • P/E Ratio
  • ASMB N/A
  • MSW $39.94
  • Revenue Growth
  • ASMB N/A
  • MSW 26.09
  • 52 Week Low
  • ASMB $9.84
  • MSW $3.70
  • 52 Week High
  • ASMB $19.93
  • MSW $10.58
  • Technical
  • Relative Strength Index (RSI)
  • ASMB 39.96
  • MSW N/A
  • Support Level
  • ASMB $13.76
  • MSW N/A
  • Resistance Level
  • ASMB $14.67
  • MSW N/A
  • Average True Range (ATR)
  • ASMB 0.72
  • MSW 0.00
  • MACD
  • ASMB -0.09
  • MSW 0.00
  • Stochastic Oscillator
  • ASMB 2.03
  • MSW 0.00

About ASMB Assembly Biosciences Inc.

Assembly Biosciences Inc is a clinical-stage biotechnology company. It is advancing two innovative platform programs, a novel class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection and novel class of oral synthetic live biotherapeutics, which are designed to restore health to a dysbiotic microbiome. The company's HBV-cure program is aimed at increasing the current low cure rate for patients with HBV and is pursuing multiple drug candidates that inhibit multiple steps of the HBV lifecycle. Assembly has discovered several novel core protein Allosteric Modulators, which are small molecules that directly target and allosterically modulate the HBV core protein. The majority of the revenue is generated from the HBV cure program.

About MSW MING SHING GROUP HOLDINGS LIMITED

Ming Shing Group Holdings Ltd is a holding company, which is primarily operated through its indirectly wholly-owned Hong Kong Operating Subsidiaries, MS (HK) Engineering Limited and MS Engineering Co., Limited. It is engaged in wet trades works, such as plastering works, tile laying works, brick laying works, floor screeding works and marble works. the company is mainly engaged in private-sector projects in Hong Kong. Its private sector projects mainly involve private residential developments and commercial developments. The project owners of its private sector projects are generally property developers, and its customers are generally main contractors and wet trades work subcontractors engaged under such projects.

Share on Social Networks: